Product Overview
CTAP(TFA） (103429-32-9 free base) | TP2050L | TargetMol Chemicals
CAS: TP2050L
Smiles: CC(O)C1C(NC(C(NC(C(N)=O)C(O)C)=O)C(C)(C)SSCC(NC(C(N)CC2=CC=CC=C2)=O)C(NC(CC3=CC=C(O)C=C3)C(NC(CC4=CNC5=CC=CC=C54)C(NC(CCC/N=C(N)\N)C(N1)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F
Formula: N/A
Pathway: Endocrinology/Hormones|||GPCR/G Protein|||Neuroscience
Target: Opioid Receptor
Receptor: N/A
Bioactivity: CTAP TFA is a potent, highly selective, and brain penetrant antagonist of μ-opioid receptor with IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP TFA can be used for the study of L-DOPA-induced dyskinesia (LID)
Molecular Weight: N/A
